Subscribe To
Intra-Cellular Therapies Reports Third Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales Guidance
Q3 2023 total revenues increased to $126.2 million, compared to $71.9 million in the same period in 2022 CAPLYTA Q3 2023 net product sales were $125.8 million, compared to $71.9 million for the same period in 2022, representing a 75% increase CAPLYTA’s strong prescription uptake continues: Q3 2023 CAPLYTA total prescriptions increased 71%, versus the same […] The post Intra-Cellular Therapies Reports Third Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales Guidance appeared first on Fo...
Read More
Posted: Nov 2 2023, 11:30
Author Name: forextv
Views: 112112